Conversations With Patients About Mild/Moderate Multiple Sclerosis


The expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.